LONDON, November 25, 2013 /PRNewswire/ --
Urology Case Reports is a new peer-reviewed, open access journal dedicated to publishing case reports in all areas of adult and pediatric urology.
Surveys of practicing urologists have shown that the time available for them to read journals, medical newspapers and attend lectures for Continuing Medical Education (CME) is diminishing. Some studies note that the average time physicians can realistically spend on furthering their education is 15 minutes per week; what they choose to read during this limited time is now ever more important.
Urology Case Reports acknowledges these time constraints whilst at the same time fulfilling educational needs. Case reports published are short and frequently well illustrated with images that can "speak a thousand words".
Kate Williamson, Publisher for Urology Case Reports at Elsevier, explains: "Many journals in the field of urology no longer publish case reports, but the need for such an outlet remains. Authors want to publish interesting case reports, which can serve as a valuable learning tool for readers. Elsevier is proud to work with Editors Dr. Partin and Dr. Wein to provide this new resource for urologists."
Dr. Partin added, "A journal like this will greatly improve our ability to share unique, interesting and educational clinical anecdotes."
The first case report published in Urology Case Reports is now available to read online on ScienceDirect. The article describes a rare neoplasm which poses a therapeutic challenge to urologists who manage patients with this rare disease: "A Case Report of Primary Recurrent Malignant Melanoma of the Urinary Bladder"
For more information or to submit an article, go to Urology Case Reports: http://www.journals.elsevier.com/urology-case-reports
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as 70 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.elsevier.com/openaccess
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.